Caption Management LLC Makes New Investment in Tenet Healthcare Corporation $THC

Key Points

• Caption Management LLC bought a new stake of 27,826 shares (~$5.65M) in Tenet Healthcare during Q3, and institutional investors now own about 95.44% of the stock.
• Corporate insiders have sold 48,695 shares (~$11.37M) in the past three months, including EVP Thomas W. Arnst (8,000 shares) and EVP Paola M. Arbour (6,500 shares), leaving insiders with just 0.81% ownership.
• Tenet reported an earnings beat (EPS $4.70 vs. $4.08 expected), set FY2026 guidance of $16.19–18.47 EPS, and analysts are largely positive with a consensus price target near $250.56.

Caption Management LLC bought a new stake in Tenet Healthcare Corporation (NYSE:THC - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 27,826 shares of the company's stock, valued at approximately $5,650,000.

Several other large investors have also recently added to or reduced their stakes in THC. William B. Walkup & Associates Inc. purchased a new position in Tenet Healthcare in the third quarter valued at about $32,000. Canada Pension Plan Investment Board acquired a new stake in shares of Tenet Healthcare in the second quarter valued at about $35,000. Westside Investment Management Inc. raised its holdings in shares of Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company's stock valued at $39,000 after buying an additional 96 shares during the period. Trust Co. of Vermont acquired a new position in Tenet Healthcare during the 3rd quarter worth approximately $41,000. Finally, Geneos Wealth Management Inc. boosted its holdings in Tenet Healthcare by 50.9% in the 2nd quarter. Geneos Wealth Management Inc. now owns 264 shares of the company's stock worth $46,000 after acquiring an additional 89 shares during the period. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 8,000 shares of the company's stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the sale, the executive vice president owned 12 shares in the company, valued at $2,866.20. This represents a 99.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the transaction, the executive vice president owned 29,291 shares of the company's stock, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 48,695 shares of company stock valued at $11,373,201 in the last three months. Corporate insiders own 0.81% of the company's stock.

Tenet Healthcare Trading Up 1.4%

THC opened at $227.79 on Friday. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $247.21. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The stock has a market capitalization of $19.81 billion, a PE ratio of 14.71, a P/E/G ratio of 1.11 and a beta of 1.39. The firm's fifty day moving average price is $213.46 and its 200 day moving average price is $203.99.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm's revenue for the quarter was up 8.9% compared to the same quarter last year. During the same period last year, the business earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

THC has been the topic of a number of analyst reports. TD Cowen reiterated a "buy" rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. KeyCorp raised their price target on shares of Tenet Healthcare from $225.00 to $250.00 and gave the company an "overweight" rating in a report on Thursday, February 12th. Weiss Ratings upgraded shares of Tenet Healthcare from a "hold (c+)" rating to a "buy (b-)" rating in a report on Monday, December 29th. Wells Fargo & Company restated an "overweight" rating and set a $265.00 target price on shares of Tenet Healthcare in a research note on Monday, February 16th. Finally, Leerink Partners lifted their target price on Tenet Healthcare from $255.00 to $264.00 and gave the stock an "outperform" rating in a research report on Friday, February 20th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $250.56.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.